AZN partnership sucking MDVN dry- MDVN=0 at best with Xtandi success
Even at maximum news hype capacity MDVN still loses millions at its peak boom. They gave away everything of value to AZN, and make 0% on sales outside the US. That's right all sales outside US goes to AZN. And even most of US sales go to AZN. MDVN = 0 even with a winner
Think Xtandi is a good drug? Buy AZN, your in the wrong stock Chief.
Bear, I dont know why you think any anti-MDVN is pro-DNDN. Fact is DNDN sucks just as bad as MDVN.. You minus well light your whole savings on fire if you buy either stock. Dont you get it? DNDN is MDVN and MDVN is DNDN. Their the same POS destined for bk in the long run.
No, they actually get a royalty - "between the low teens and the low twenties" percentagewise - on sales outside the US. They bear none of the costs for developing this market. And, assuming they meet various goals, they are eligible to receive $650 million more from Astellas. Of course, it's possible that you have a sharper pencil than the Goldman-Sachs analyst. Again, I'd suggest that today proves definitively that DNDN is the wrong stock.
So first the stockgenius lies and says they get nothing for foreign sales and than when corrected scoffs at the 10-20% royalty they get. What a class act. And considering they only get half of US sales while splitting costs the foreign deal looks pretty good.
Lol you call 10-20% royalty a slice of the pie for the lead drug maker? whoever negotiated the deal between AZN and MDVN was secretly working on AZN's side obviously, MDVN got F'ed in the A bigtime, hell I dont even care if the drug succeeds cause insiders at MDVN negotiated themselves the worst deal I have ever seen in pharmaceutical partnership.